Evogene (TASE:EVGN) announced today the appointment of 20 new employees in the scientific teams. This Human Resource expansion in the R&D was carried out in Evogene's core scientific areas: Computational Genomics, Development of New Core Technologies, Trait Improvement and Experimental Genomics. 14 of the new team members hold PhD degrees.

Ofer Haviv, Evogene's president and CEO stated: "The recruitment of 13 new employees in the scientific and business teams, being announced today, is targeted at supporting mainly our computational genomics capabilities and the scientific research expertise. This growth in Human Resource is expected to enable us to pursue our activities under the collaborations with world leading seed companies that the company has committed to, which significantly increased in the second half of 2011, the further development of new computational technologies with an emphasis on Gene2ProductTM and EvoBreedTM and the preparation for entries into new business fields, such as Ag-chemicals."

distribué par

Ce noodl a été diffusé par Evogene Ltd. et initialement mise en ligne sur le site http://www.evogene.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-10 15:29:13 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.